Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.

Rockey DC, Vierling JM, Mantry P, Ghabril M, Brown RS Jr, Alexeeva O, Zupanets IA, Grinevich V, Baranovsky A, Dudar L, Fadieienko G, Kharchenko N, Klaryts'ka I, Morozov V, Grewal P, McCashland T, Reddy KG, Reddy KR, Syplyviy V, Bass NM, Dickinson K, Norris C, Coakley D, Mokhtarani M, Scharschmidt BF; HALT-HE Study Group.

Hepatology. 2014 Mar;59(3):1073-83. doi: 10.1002/hep.26611.

2.

Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.

Mikhailova TL, Sishkova E, Poniewierka E, Zhidkov KP, Bakulin IG, Kupcinskas L, Lesniakowski K, Grinevich VB, Malecka-Panas E, Ardizzone S, D'Arienzo A, Valpiani D, Koch M, Denapiene G, Vago G, Fociani P, Zerbi P, Ceracchi M, Camerini R, Gasbarrini G.

Aliment Pharmacol Ther. 2011 Nov;34(9):1088-97. doi: 10.1111/j.1365-2036.2011.04844.x. Epub 2011 Sep 19.

PMID:
21929562
3.

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

Low DE, File TM Jr, Eckburg PB, Talbot GH, David Friedland H, Lee J, Llorens L, Critchley IA, Thye DA; FOCUS 2 investigators.

J Antimicrob Chemother. 2011 Apr;66 Suppl 3:iii33-44. doi: 10.1093/jac/dkr097.

4.

3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial.

Gross V, Bunganic I, Belousova EA, Mikhailova TL, Kupcinskas L, Kiudelis G, Tulassay Z, Gabalec L, Dorofeyev AE, Derova J, Dilger K, Greinwald R, Mueller R; International BUC-57 Study Group.

J Crohns Colitis. 2011 Apr;5(2):129-38. doi: 10.1016/j.crohns.2010.11.006. Epub 2010 Dec 14.

5.

Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis.

Kruis W, Jonaitis L, Pokrotnieks J, Mikhailova TL, Horynski M, Bátovský M, Lozynsky YS, Zakharash Y, Rácz I, Kull K, Vcev A, Faszczyk M, Dilger K, Greinwald R, Mueller R; International Salofalk OD Study Group.

Aliment Pharmacol Ther. 2011 Feb;33(3):313-22. doi: 10.1111/j.1365-2036.2010.04537.x. Epub 2010 Dec 8.

PMID:
21138455
6.

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

Corey GR, Wilcox MH, Talbot GH, Thye D, Friedland D, Baculik T; CANVAS 1 investigators.

J Antimicrob Chemother. 2010 Nov;65 Suppl 4:iv41-51. doi: 10.1093/jac/dkq254.

7.

Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.

Bergmann JF, Cohen AT, Tapson VF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Anderson FA Jr; ENDORSE Investigators.

Thromb Haemost. 2010 Apr;103(4):736-48. doi: 10.1160/TH09-09-0667. Epub 2010 Feb 2.

PMID:
20135072
8.

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial.

Kruis W, Kiudelis G, Rácz I, Gorelov IA, Pokrotnieks J, Horynski M, Batovsky M, Kykal J, Boehm S, Greinwald R, Mueller R; International Salofalk OD Study Group.

Gut. 2009 Feb;58(2):233-40. doi: 10.1136/gut.2008.154302. Epub 2008 Oct 2.

9.

[Clinical pathomorphology of critical conditions].

Rybakova MG, Zhidkov KP, Klechikov VZ.

Arkh Patol. 2005 Sep-Oct;67(5):41-8. Russian.

PMID:
16323482
10.

[A case of respiratory distress syndrome complicated by the development of interstitial emphysema and pneumomediastinum].

Zhidkov KP, Bogatyr' MN, Chezhin AN, Leĭman VA, Smirnova OR.

Anesteziol Reanimatol. 2000 May-Jun;(3):62-4. Review. Russian.

PMID:
10900727
11.

[Experience in the treatment of severe forms of sepsis by extracorporeal therapy and hyperbaric oxygenation].

Zhidkov KP, Klechikov VZ, Bogatyr' MN.

Anesteziol Reanimatol. 1997 May-Jun;(3):49-51. Russian.

PMID:
9289988
12.

[Structural-functional changes to the surface of human erythrocytes during autotransfusions of blood treated with a hemosorbent].

Artsishevskaia RA, Zhidkov KP.

Vestn Khir Im I I Grek. 1993 Jan-Feb;150(1-2):80-5. Russian. No abstract available.

PMID:
7701713
13.

[Dynamics of blood lymphocyte blast-transformation parameters during hemosorption in patients with gastric ulcer].

Zhidkov KP, Fedorova LA, Polevshchikov AV, Nazarov PG.

Gematol Transfuziol. 1992 Mar;37(3):15-7. Russian.

PMID:
1516792
14.

[Dynamics of production of interleukin-1 by monocytes after hemosorption in patients with peptic ulcer].

Ketlinskiĭ SA, Zhidkov KP, Pigareva NV.

Vestn Khir Im I I Grek. 1991 Feb;146(2):100-2. Russian.

PMID:
1652805
16.

[Autotransfusions of sorbent blood in treating peptic ulcer patients with an unfavorable course].

Uspenskiĭ VM, Zhidkov KP, Malygin AM, Shevchenko EV.

Vrach Delo. 1990 Aug;(8):41-3. Russian.

PMID:
2256284
17.

[Dynamics of neutrophilic enzyme indicators in patients with peptic ulcer after autologous blood transfusion and hemosorption].

Zhidkov KP, Rogaleva EIu, Shliapochnikova GP, Iazovitskaia LM, Fomenko LL.

Vestn Khir Im I I Grek. 1990 Jan;144(1):95-7. Russian.

PMID:
2165338
18.

[A method of extracorporeal perfusion of the sections of xenogeneic spleen].

Borisov AE, Zhidkov KP, Dmitriev NV, Domanskaia IA.

Vestn Khir Im I I Grek. 1989 Jul;143(7):24-5. Russian.

PMID:
2595920
19.
20.

[Hemosorption in the treatment of stomach ulcer].

Zhidkov KP, Vashchenko VM, Ryndin AA, Gornachev BI.

Vestn Khir Im I I Grek. 1988 Oct;141(10):122-4. Russian. No abstract available.

PMID:
3242220
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk